Advances in the Study of Schistosomiasis: The Postgenomic Era (original) (raw)

Schistosomiasis remains a serious global health concern, affecting over 200 million people and resulting in significant annual disability-adjusted life years (DALYs). While current treatments are available, the disease's prevalence continues, urging the need for new drugs, vaccines, and diagnostic methods. The availability of schistosome genome sequences provides an opportunity to enhance understanding of parasite biology and improve control strategies. Recent studies have focused on the immunological responses in infected individuals, the interaction of parasite antigens with the host's immune system, and the implications for future schistosomiasis research.